Metabolic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma.

Renée Maria Saliby(Yale University), David A. Braun(Yale Cancer Center), Dustin McCurry(The University of Texas MD Anderson Cancer Center), Deepak Poduval(Yale University), Juan Gallegos(Baylor College of Medicine), Eliezer M. Van Allen(Dana-Farber Cancer Institute), Sabina Signoretti(Brigham and Women's Hospital), Toni K. Choueiri(Harvard University), Valisha Shah(Dana-Farber Cancer Institute), Nourhan El Ahmar(Brigham and Women's Hospital), Aseman Sheshdeh Bagheri(Brigham and Women's Hospital), Tejas Jammihal(Children's Hospital of Philadelphia), Sachet A. Shukla(The University of Texas MD Anderson Cancer Center), Yasmin Nabil Laimon(Brigham and Women's Hospital), Hanna Soulati(Yale Cancer Center), Marc Eid(Harvard University), A.C. Polo i Peris(The University of Texas MD Anderson Cancer Center), Katherine M. Krajewski(Brigham and Women's Hospital), Talal El Zarif(Yale University), Chris Labaki(Beth Israel Deaconess Medical Center)
Journal of Clinical Oncology
February 10, 2025
Cited by 1


Related Papers